Stocks
Cara Therapeutics (CARA) ROE US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 3.38% | -38.8% | -52.5% | -207.6% | -207.6% | -13 511% | ||
| Changes by years, y/y, % | +60pp | -42pp | -14pp | -155pp | 0pp | +30.2% | |||
Cara Therapeutics. ROE, %
Cara Therapeutics. ROE, changes, pp
Cara Therapeutics (CARA) ROE US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | -205.9% | -205.9% | -411.2% | -957.8% | -13 511% | -13 511% | |
| Changes by years, y/y, % | -153pp | -153pp | -352pp | -858pp | -13 378pp | |||
| Changes by quarters, q/q, % | -72pp | 0pp | -205pp | -547pp | -12 554pp | |||
